Fact CheckerSign in

NCT05200351Recruiting

Equine-assisted Therapy for Therapy-resistant Adolescents With Autism Spectrum Disorders, a Replicated AB-design

Source: ClinicalTrials.gov · Last updated 4 Nov 2024 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

The purpose of this study is to assess the (cost)effectivity of Equine assisted Therapy in adolescents with Autism Spectrum disorders.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
35 (estimated)
First submitted
17 Dec 2021
Start date
14 Feb 2022
Primary completion date
Dec 2024
Lead sponsor
Karakter Kinder- en Jeugdpsychiatrie
Diseases
Autism
NCT number
NCT05200351

What you commit to

  • Study type: Interventional
  • Planned participants: 35
  • From 14 Feb 2022 to the primary completion date, Dec 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • unstable medication use;
  • therapy with horses within the last two years.

Other illness

  • allergic or phobic to horses;

Other

  • unable to respond to questions (parents or adolescents);
  • no access to an Internet connection;
  • insufficient mastery of Dutch language in parents or adolescents;
  • physically incapable to work with the horses;
  • total intelligence quotient (IQ) equal to or below 80 on the Wechsler Intelligence Scale for Children (WISC-III-R or WISC-V);
  • insufficient regulation to safely handle the horses;

Who the study is looking for

  • between 11-18 years old;
  • a clinical diagnosis of autism spectrum disorders according the Diagnostic and Statistical Manual of Mental Disorders 5 (DSM 5) as diagnosed by a Beroepen in de Individuele Gezondheidszorg (BIG) registered healthcare professional;
  • insufficient emotion regulation after regular therapy for at least 1,5 years as indicated by a score above clinical cut-off (T-score = 65) on the EDI;
  • comorbidities are allowed except for those interfering with safety.

Age in the registry: 11 years to 18 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Karakter
Coordinator of this site? Confirm its status
EdeNetherlandsRecruiting
Horses & Co
Coordinator of this site? Confirm its status
HeerjansdamNetherlandsRecruiting
De Gagelhoeve
Coordinator of this site? Confirm its status
MillNetherlandsRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.